These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26733983)

  • 21. A Lactic Acid Bacteria (LAB)-Based Vaccine Candidate for Human Norovirus.
    Craig K; Dai X; Li A; Lu M; Xue M; Rosas L; Gao TZ; Niehaus A; Jennings R; Li J
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30832363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein.
    Zhu Y; Ma Y; Lu M; Zhang Y; Li A; Liang X; Li J
    Viruses; 2019 May; 11(5):. PubMed ID: 31100802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope mapping of histo blood group antigens bound to norovirus VLPs using STD NMR experiments reveals fine details of molecular recognition.
    Fiege B; Leuthold M; Parra F; Dalton KP; Meloncelli PJ; Lowary TL; Peters T
    Glycoconj J; 2017 Oct; 34(5):679-689. PubMed ID: 28823097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterologous expression of human norovirus GII.4 VP1 leads to assembly of T=4 virus-like particles.
    Devant JM; Hofhaus G; Bhella D; Hansman GS
    Antiviral Res; 2019 Aug; 168():175-182. PubMed ID: 31145925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of virus-like particles derived from a GII.3 norovirus strain distantly related with current dominating strains.
    Huo Y; Chen X; Zheng L; Huo J; Zhang S; Wang M; Wang Y
    Virus Genes; 2016 Oct; 52(5):613-9. PubMed ID: 27234312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-assembly of the recombinant capsid protein of a bovine norovirus (BoNV) into virus-like particles and evaluation of cross-reactivity of BoNV with human noroviruses.
    Han MG; Wang Q; Smiley JR; Chang KO; Saif LJ
    J Clin Microbiol; 2005 Feb; 43(2):778-85. PubMed ID: 15695679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China.
    Huo Y; Zheng L; Chen X; Ge L; Wang Y
    Microb Pathog; 2017 Apr; 105():131-137. PubMed ID: 28219831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions.
    Lochridge VP; Jutila KL; Graff JW; Hardy ME
    J Gen Virol; 2005 Oct; 86(Pt 10):2799-2806. PubMed ID: 16186235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural Basis for Human Norovirus Capsid Binding to Bile Acids.
    Kilic T; Koromyslova A; Hansman GS
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural Basis of Nanobodies Targeting the Prototype Norovirus.
    Ruoff K; Kilic T; Devant J; Koromyslova A; Ringel A; Hempelmann A; Geiss C; Graf J; Haas M; Roggenbach I; Hansman G
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and purification of norovirus virus like particles in Escherichia coli and their immunogenicity in mice.
    Huo Y; Wan X; Ling T; Wu J; Wang W; Shen S
    Mol Immunol; 2018 Jan; 93():278-284. PubMed ID: 28802994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human noroviruses' fondness for histo-blood group antigens.
    Singh BK; Leuthold MM; Hansman GS
    J Virol; 2015 Feb; 89(4):2024-40. PubMed ID: 25428879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies.
    Crawford SE; Ajami N; Parker TD; Kitamoto N; Natori K; Takeda N; Tanaka T; Kou B; Atmar RL; Estes MK
    Clin Vaccine Immunol; 2015 Feb; 22(2):168-77. PubMed ID: 25428246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives.
    Kocher J; Yuan L
    Future Virol; 2015; 10(7):899-913. PubMed ID: 26568768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Noroviruses--tactic of spread].
    Gospodarek E; Zalas-Wiecek P
    Przegl Epidemiol; 2009; 63(1):5-9. PubMed ID: 19522218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzymatic cleavage promotes disassembly of GII.3 norovirus virus like particles and its binding to salivary histo-blood group antigens.
    Huo Y; Wang W; Zheng L; Chen X; Shen S; Wang M
    Virus Res; 2017 Aug; 240():18-24. PubMed ID: 28754559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pandemic GII.4 Sydney and Epidemic GII.17 Kawasaki308 Noroviruses Display Distinct Specificities for Histo-Blood Group Antigens Leading to Different Transmission Vector Dynamics in Pacific Oysters.
    Morozov V; Hanisch FG; Wegner KM; Schroten H
    Front Microbiol; 2018; 9():2826. PubMed ID: 30542329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors.
    Tan M; Hegde RS; Jiang X
    J Virol; 2004 Jun; 78(12):6233-42. PubMed ID: 15163716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus.
    Koho T; Huhti L; Blazevic V; Nurminen K; Butcher SJ; Laurinmäki P; Kalkkinen N; Rönnholm G; Vesikari T; Hytönen VP; Kulomaa MS
    J Virol Methods; 2012 Jan; 179(1):1-7. PubMed ID: 21600929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic and biological characterization of a pandemic norovirus variant GII.4 Sydney 2012.
    Ge L; Chen X; Liu J; Zheng L; Chen C; Luo S; Guo P; Kong J; Song Y; Huo Y
    Virus Genes; 2020 Apr; 56(2):174-181. PubMed ID: 31912284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.